Overview

NextGen - Clinical Implication of Next Generation Sequencing

Status:
Not yet recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
Recently more advanced techniques, including Polymerase Chain Reaction (PCR) and Next Generation Sequencing (NGS) are available to detect bacteria in urine based on bacterial genomes. Comparing to traditional culture, these techniques have more sensitivity and could potentially be of a great help in patients with Colony Count of less than 10,000 and more than zero.
Phase:
Phase 4
Details
Lead Sponsor:
Wake Forest University Health Sciences
Treatments:
Amoxicillin
Ampicillin
Anti-Bacterial Agents
Cephalosporins
Clindamycin
Fluoroquinolones
Fosfomycin
Linezolid
Metronidazole
Nitrofurantoin
Penicillins
Tetracycline